These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8001619)

  • 21. [alpha-Glucosidase inhibitors in the therapy of diabetes mellitus].
    Giorgino R; Damato A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():61S-65S. PubMed ID: 8562269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
    Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
    Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolving role of alpha-glucosidase inhibitors.
    Göke B; Herrmann-Rinke C
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S31-8. PubMed ID: 9816485
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acarbose and diabetes. Slight improvement or authentic therapeutic progress?].
    Costa B
    Med Clin (Barc); 1995 Sep; 105(9):341-3. PubMed ID: 7500688
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of acarbose in the treatment of diabetes mellitus].
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):385-90. PubMed ID: 9805654
    [No Abstract]   [Full Text] [Related]  

  • 26. [Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
    Fehmann HC
    MMW Fortschr Med; 2000 May; 142(21):55. PubMed ID: 10872296
    [No Abstract]   [Full Text] [Related]  

  • 27. The mechanism of alpha-glucosidase inhibition in the management of diabetes.
    Bischoff H
    Clin Invest Med; 1995 Aug; 18(4):303-11. PubMed ID: 8549017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress in the treatment of diabetes mellitus.
    Mirouze J
    Adv Nephrol Necker Hosp; 1986; 15():307-27. PubMed ID: 3082115
    [No Abstract]   [Full Text] [Related]  

  • 29. An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
    Reuser AJ; Wisselaar HA
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():19-24. PubMed ID: 8001622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alpha glucosidase inhibitor].
    Katsuta H; Ishida H
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():637-45. PubMed ID: 17458296
    [No Abstract]   [Full Text] [Related]  

  • 31. New horizons in diabetes therapy--alpha glucosidase inhibitors.
    Jawad F
    J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
    [No Abstract]   [Full Text] [Related]  

  • 32. Discovery and biological evaluation of novel alpha-glucosidase inhibitors with in vivo antidiabetic effect.
    Park H; Hwang KY; Kim YH; Oh KH; Lee JY; Kim K
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3711-5. PubMed ID: 18524587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S; Turco S; Guarino G; Oliviero B; Rustici A; Torella R
    Ann Ital Med Int; 1999; 14(1):7-14. PubMed ID: 10528419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of alpha-inhibitors on blood glucose and insulin levels.
    Laube H; Federlin K; Hillebrand I
    Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
    [No Abstract]   [Full Text] [Related]  

  • 35. [The combined treatment of patients with type-2 diabetes mellitus].
    Rakov AL; Chugunova LG
    Voen Med Zh; 1996 Nov; 317(11):30-4. PubMed ID: 9036627
    [No Abstract]   [Full Text] [Related]  

  • 36. Newer hypoglycaemic agents-its relevance.
    Shah SN; Ajmera J
    J Assoc Physicians India; 1993 Nov; 41(11):699. PubMed ID: 8005919
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analogues of amylin, alpha-glucosidase inhibitors and the digestive system in homeostasis regulation].
    Rybka J
    Vnitr Lek; 2011 Apr; 57(4):381-7. PubMed ID: 21612064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.
    Calle-Pascual A; Garcia-Honduvilla J; Martin-Alvarez PJ; Calle JR; Maranes JP
    Diabetes Metab; 1996 Jun; 22(3):201-2. PubMed ID: 8697309
    [No Abstract]   [Full Text] [Related]  

  • 39. Geriatric pharmacology: drugs used in the management of diabetes mellitus.
    Cuddy ML
    J Pract Nurs; 2004; 54(4):18-23; quiz 24-5. PubMed ID: 15730185
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
    Gendeleka GF
    Lik Sprava; 1997; (6):105-7. PubMed ID: 9589946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.